ID
33820
Description
A Phase 3, Comparative Study of Asunaprevir and Daclatasvir Combination Therapy Versus Telaprevir Therapy in Japanese HCV Subjects; ODM derived from: https://clinicaltrials.gov/show/NCT01718145
Link
https://clinicaltrials.gov/show/NCT01718145
Keywords
Versions (1)
- 1/2/19 1/2/19 -
Copyright Holder
See clinicaltrials.gov
Uploaded on
January 2, 2019
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Hepatitis C Virus Infection NCT01718145
Eligibility Hepatitis C Virus Infection NCT01718145
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
Patients Have
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0030705
- UMLS CUI [1,2]
- C3539897
Description
Liver carcinoma
Data type
boolean
Alias
- UMLS CUI [1]
- C2239176
Description
HBV coinfection | HIV coinfection
Data type
boolean
Alias
- UMLS CUI [1]
- C2242656
- UMLS CUI [2]
- C4062778
Description
Severe complication | Complication Uncontrolled
Data type
boolean
Alias
- UMLS CUI [1]
- C3495031
- UMLS CUI [2,1]
- C0009566
- UMLS CUI [2,2]
- C0205318
Similar models
Eligibility Hepatitis C Virus Infection NCT01718145
- StudyEvent: Eligibility
C3494965 (UMLS CUI [1,2])
C0599755 (UMLS CUI [2,1])
C0919936 (UMLS CUI [2,2])
C0599755 (UMLS CUI [3,1])
C0277556 (UMLS CUI [3,2])
C0919936 (UMLS CUI [1,2])
C3827727 (UMLS CUI [1,2])
C0332157 (UMLS CUI [2,1])
C0279030 (UMLS CUI [2,2])
C0369335 (UMLS CUI [3,1])
C3830527 (UMLS CUI [3,2])
C3274571 (UMLS CUI [3,3])
C3539897 (UMLS CUI [1,2])
C4062778 (UMLS CUI [2])
C0009566 (UMLS CUI [2,1])
C0205318 (UMLS CUI [2,2])